FUJIFILM Wako Chemicals Europe GmbH +49-2131-311-0 info_wkeu@fujifilm.com
µTASWako™ DCP Test

µTASWako™ DCP Test

Select a component please.

Ready-to-use test components:

µTASWako™ DCP Test is an  in vitro  diagnostic blood test for the risk assessment of... more

Product information

µTASWako™ DCP Test is an in vitro diagnostic blood test for the risk assessment of developing Hepatocellular Carcinoma (HCC).

DCP (des-gamma-carboxy prothrombin) is an immature form of the coagulation protein, prothrombin. In the normal metabolism the prothrombin precursor undergoes a vitamin K dependent of carboxylation of 10 glutamicacid residues at the N-terminus to yield the native prothrombin. In the case of HCC, this transformation is impaired, which results in an accumulation of DCP. DCP is also known as protein induced by vitamin K absence or antagonist II (PIVKA-II).

µTASWako™ DCP Test allows an early diagnosis of HCC and is run on the µTASWako i30 device.

All test components are CE-certified according to Directive 98/79/EC on in vitro diagnostic medical devices.

 

Click here for more information for Health Care Providers.

Key Features

  • CE-marked in vitro diagnostic test
  • Superior specificity for HCC

Storage

Store at 2-10° C.

Safety Information

Icon: Gesundheitsgefahr
Health Hazard

Literature

For more information and the latest publications please visit the Mediacenter.

Are you interested in "µTASWako™ DCP Test" and need more information?

Viewed
Englisch